Parker Institute For Cancer Immunotherapy
- Assets
- $159.3m
- Revenue
- $162.6m
- Investments
- $2.0m
- Employees
- 88
- Location
- San Francisco, CA
- Founding
- 06/2015
- Data as of
- 12/2019
- EIN
- 47-3355381
Parker Institute For Cancer Immunotherapy Overview
Parker Institute For Cancer Immunotherapy is located in San Francisco, CA. The organization was established in 2015. According to its NTEE Classification (E12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Health Care and related organizations. As of 12/2019, Parker Institute For Cancer Immunotherapy employed 88 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations.
For the year ending 12/2019, Parker Institute For Cancer Immunotherapy generated $162.6m in total revenue. This organization has experienced exceptional growth, as over the past 5 years, it has increased revenue by an average of 17.2% each year . All expenses for the organization totaled $78.0m during the year ending 12/2019. While expenses have increased by 2.4% per year over the past 5 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Parker Institute For Cancer Immunotherapy has awarded 56 individual grants totaling $185,874,997. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2019
Describe the Organization's Mission:
Part 3 - Line 1
THE PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY (PICI) WAS CREATED TO ENCOURAGE ADVANCES IN CANCER IMMUNOTHERAPY RESEARCH AND TO HELP REDUCE OBSTACLES TO COLLABORATION, DISCOVERY AND TRANSLATION OF THESE ADVANCES FOR PATIENTS. PICI ACHIEVES THIS GOAL BY FUNDING A CONSORTIUM OF PREEMINENT ACADEMIC AND MEDICAL RESEARCH INSTITUTIONS WHICH WORK COLLABORATIVELY ON RESEARCH IN THE FIELD OF CANCER IMMUNOTHERAPY. IN ADDITION, PICI FURTHERS ITS CHARITABLE PURPOSES BY EMPLOYING ITS OWN PERSONNEL TO DIRECTLY CONDUCT RESEARCH AND CLINICAL TRIALS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
PICI ENCOURAGES ADVANCES IN CANCER IMMUNOTHERAPY RESEARCH, COLLABORATION, AND DISCOVERY, AND THE TRANSLATION OF THESE ADVANCES INTO CURES AND TREATMENTS FOR THE BENEFIT OF PATIENTS. TO DO THIS, PICI CONDUCTS ITS OWN RESEARCH AND CLINICAL TRIALS AND PROVIDES ITS CONSORTIUM OF PREEMINENT HOSPITALS AND ACADEMIC RESEARCH CENTERS WITH SHARED RESEARCH RESOURCES, SUCH AS SCIENTIFIC EQUIPMENT, CONSUMABLES, BIOINFORMATICS ANALYSIS, AND A SPECIMEN BIOBANK. PICI ALSO FUNDS AND OTHERWISE SUPPORTS CANCER IMMUNOTHERAPY RESEARCH WITHIN ITS CONSORTIUM.
Do You Work With Nonprofits?Intellispect helps service providers identify nonprofit prospects and make contact with decision makers.
Parker Institute For Cancer Immunotherapy Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Ramy Ibrahim Chief Medical Officer | Officer | 40 | $884,132 |
Jeffrey A Bluestone PHD President/ceo & Director | OfficerTrustee | 40 | $709,428 |
Frederick J Ramsdell Chief Scientific Officer (thru 12/19) | 40 | $432,060 | |
Nikesh Kotecha Vp-Informatics | 40 | $417,850 | |
Theresa Lavallee Vp-Translational Medicine | 40 | $416,755 | |
Melinda Griffith Chief Legal Counsel, Vp-St | 40 | $409,259 |
Parker Institute For Cancer Immunotherapy Vendors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Precision Cancer Research Biostorage And Sample Processing | 12/30/19 | $1,562,828 |
Clinlogix Clinical Trial Monitoring | 12/30/19 | $726,294 |
Greenphire Clinical Trial Payment Processing | 12/30/19 | $1,074,374 |
Biostorage Technologies Inc Biostorage And Sample Processing | 12/30/19 | $972,929 |
Aris Clinical Inc Clinical Trial Monitoring | 12/30/19 | $1,340,873 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $146,644,584 |
| Noncash contributions included in lines 1a–1f | $50,092,869 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $146,644,584 |
| Total Program Service Revenue | $15,232,654 |
| Investment income | $771,326 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $162,648,564 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $34,963,492 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $2,052,973 |
| Compensation of current officers, directors, key employees. | $572,955 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $13,105,701 |
| Pension plan accruals and contributions | $288,800 |
| Other employee benefits | $1,343,463 |
| Payroll taxes | $821,204 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $1,243,380 |
| Fees for services: Accounting | $92,327 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $200,000 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $6,502,118 |
| Advertising and promotion | $70,695 |
| Office expenses | $3,143,818 |
| Information technology | $718,268 |
| Royalties | $0 |
| Occupancy | $1,350,847 |
| Travel | $456,032 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $2,022,633 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $1,911,495 |
| Insurance | $261,608 |
| All other expenses | $563,016 |
| Total functional expenses | $77,964,615 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $13,206,800 |
| Savings and temporary cash investments | $60,821,581 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $150,091 |
| Loans from Officers, Directors, or Controlling Persons | $280,000 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $699,005 |
| Net Land, buildings, and equipment | $4,441,812 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $2,000,000 |
| Investments—program-related | $77,326,575 |
| Intangible assets | $0 |
| Other assets | $326,617 |
| Total assets | $159,252,481 |
| Accounts payable and accrued expenses | $10,653,415 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $10,653,415 |
| Net assets without donor restrictions | $148,272,449 |
| Net assets with donor restrictions | $326,617 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $159,252,481 |
Parker Institute For Cancer Immunotherapy Grants Awarded
Over the last fiscal year, Parker Institute For Cancer Immunotherapy has awarded $34,385,416 in support to 13 organizations.
| Grant Recipient | Amount |
|---|---|
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $10,042,040 |
San Francisco, CA PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $5,593,452 |
Philadelphia, PA PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $5,452,600 |
New York, NY PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $4,352,647 |
Redwood City, CA PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $2,425,569 |
Los Angeles, CA PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $2,260,431 |
Parker Institute For Cancer Immunotherapy Grants Recieved
Over the last fiscal year, we have identified 1 grants that Parker Institute For Cancer Immunotherapy has recieved totaling $397,293.
| Awarding Organization | Amount |
|---|---|
Jdrf International New York, NY PURPOSE: IMMUNOTHERAPIES | $397,293 |
Parker Institute For Cancer Immunotherapy Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Faculty Physicians And Surgeons Of Llusm Loma Linda, CA | $258,281,985 | $570,353,741 |
Memorial Health Services Fountain Valley, CA | $2,790,238,727 | $283,777,110 |
Parker Institute For Cancer Immunotherapy San Francisco, CA | $159,252,481 | $162,648,564 |
California Healthcare Foundation Oakland, CA | $741,030,213 | $19,485,198 |
Valley Childrens Healthcare Foundation Madera, CA | $36,022,003 | $37,286,237 |
Saint Johns Hospital & Health Center Foundation Santa Monica, CA | $257,764,287 | $81,355,045 |
Honorhealth Foundation Scottsdale, AZ | $248,799,750 | $41,438,348 |
The Health Trust San Jose, CA | $138,810,819 | $21,227,060 |
Health First Foundation-Northern Arizona Flagstaff, AZ | $42,473,817 | $4,696,577 |
Healthcare Transitional Funding Corp Glendale, AZ | $463,333 | $25,480 |
Childrens Healthcare Of California Orange, CA | $439,197,724 | $38,227,674 |
Community Clinics Health Network San Diego, CA | $1,403,743 | $5,160,388 |
Create a Free Account